• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,025.19 -173.50
(-0.33%)
Dow Jones
7,682.22 -82.84
(-1.07%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,879.96 39.61
(0.37%)
Forex
USD-INR
94.85 -0.23
(-0.24%)
EUR-INR
106.35 0.11
(0.11%)
GBP-INR
125.73 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.07%)

EQUITY - MARKET SCREENER

Va Tech Wabag Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
533269
INE956G01038
337.2164652
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WABAG
33.06
11779.98
EPS(TTM)
Face Value()
Div & Yield %
57
2
0.27
 

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
May 13,2026
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales256.99197.99 30 927.11809.73 15
OPM %17.2910.65 -17.6915.65 -
PBDT53.5931.48 70 225.56155.06 45
PBT44.9223.44 92 192.08125.64 53
NP35.5815.54 129 129.1384.30 53